Response to: Kumar N, Ahmed M. Letter to the editor in response to Komen et al. 2021

Eur Heart J Cardiovasc Pharmacother. 2021 May 23;7(3):e31. doi: 10.1093/ehjcvp/pvab028.

Joris J Komen^{1

2}, Tomas Forslund^{2

3}, Aukje K Mantel-Teeuwisse¹, Olaf H Klungel¹, Mia von Euler^{3

4}, Frieder Braunschweig⁵, Håkan Wallén⁶, Paul Hjemdahl³

¹ Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Unversiteitsweg 99, 3584CG Utrecht, The Netherlands.
² Department of Healthcare Development, Stockholm County Council, Stockholm, Sweden.
³ Clinical Pharmacology Unit, Clinical Epidemiology Division, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.
⁴ Department of Clinical Science and Education, Karolinska Institutet Stroke Research Network at Södersjukhuset, Stockholm, Sweden.
⁵ Department of Cardiology, Karolinska Institute, Karolinska University Hospital, Stockholm, Sweden.
⁶ Division of Cardiovascular Medicine, Department of Clinical Sciences, Karolinska Institutet, Danderyd Hospital, Stockholm, Sweden.

No abstract available

Publication types